Internal Medicine, Rheumatology · Port Charlotte, FL
NPI
1457397069
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2841 Tamiami Trl
Port Charlotte, FL, 33952
Phone (941) 627-5151
Medicare paid, 2024
$177K
2,583 services
Medicare patients, 2024
619
Average age 75
Drug cost, 2024
$4.6M
4,902 prescriptions
Company payments, 2024
$692
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sash Seshadri was code 99214 (office e&m - established), 1,644 times for 571 patients. In total Sash Seshadri billed 2,583 services in 20 codes, and Medicare paid $177K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,644 | 571 | $88.95 | $146K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 278 | 42 | $0.68 | $190 |
| 99213 Office E&M - Established | Office | 192 | 125 | $62.44 | $12K |
| 99204 Office E&M - New | Office | 86 | 86 | $103.59 | $8,909 |
| 20611 Joint Injection | Office | 70 | 38 | $66.28 | $4,639 |
By year: 2022 $210K for 3,760 services; 2023 $208K for 4,400 services; 2024 $177K for 2,583 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sash Seshadri prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 774 prescriptions and refills. In total Sash Seshadri wrote 4,902 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 774 | 2,035 | 232 | $26K |
| Prednisone Generic | 609 | 1,298 | 213 | $4,410 |
| Methotrexate Methotrexate Sodium | 567 | 1,503 | 192 | $13K |
| Leflunomide Generic | 336 | 818 | 96 | $22K |
| Folic Acid Generic | 241 | 635 | 78 | $2,483 |
| Sulfasalazine Generic | 206 | 508 | 71 | $5,001 |
| Gabapentin Generic | 190 | 494 | 65 | $4,202 |
| Tramadol Hcl Generic | 159 | 207 | 30 | $1,846 |
| Enbrel Sureclick Etanercept | 142 | 162 | 20 | $1.2M |
| Tizanidine Hcl Generic | 101 | 237 | 34 | $1,555 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 87 | 87 | 17 | $1,945 |
| Duloxetine Hcl Generic | 76 | 197 | 22 | $2,042 |
| Mycophenolate Mofetil Generic | 73 | 188 | 28 | $10K |
| Methylprednisolone Generic | 73 | 103 | 53 | $758 |
| Humira(Cf) Pen Adalimumab | 71 | 73 | 11 | $566K |
Brand drugs: 843 claims; generic drugs: 4,042 claims; opioid claims: 250.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Sash Seshadri $692 ($692 in general payments such as food, travel and fees) from 8 companies. The largest payer was Abbvie Inc. with $283.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.